These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11589508)

  • 21. Lack of saturable transport across the blood-brain barrier in either direction for beta-amyloid1-28 (Alzheimer's disease protein).
    Banks WA; Kastin AJ; Barrera CM; Maness LM
    Brain Res Bull; 1991 Dec; 27(6):819-23. PubMed ID: 1786560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Yang X; Zhao H; Shi H; Wang X; Zhang S; Zhang Z; Zu J; Zhang W; Shen X; Cui G; Hua F
    Exp Neurol; 2015 Sep; 271():168-74. PubMed ID: 26001615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse.
    Banks WA; Goulet M; Rusche JR; Niehoff ML; Boismenu R
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1062-9. PubMed ID: 12183664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.
    Banks WA; Kastin AJ; Komaki G; Arimura A
    J Pharmacol Exp Ther; 1993 Nov; 267(2):690-6. PubMed ID: 8246142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.
    Banks WA; Schally AV; Barrera CM; Fasold MB; Durham DA; Csernus VJ; Groot K; Kastin AJ
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6762-6. PubMed ID: 1975697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls.
    Kastin AJ; Akerstrom V; Pan W
    Peptides; 2001 Dec; 22(12):2127-36. PubMed ID: 11786200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permeation of hepatocyte growth factor across the blood-brain barrier.
    Pan W; Yu Y; Yemane R; Cain C; Yu C; Kastin AJ
    Exp Neurol; 2006 Sep; 201(1):99-104. PubMed ID: 16733055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Food deprivation decreases blood galanin-like peptide and its rapid entry into the brain.
    Kastin AJ; Akerstrom V; Hackler L
    Neuroendocrinology; 2001 Dec; 74(6):423-32. PubMed ID: 11752898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entry of EGF into brain is rapid and saturable.
    Pan W; Kastin AJ
    Peptides; 1999; 20(9):1091-8. PubMed ID: 10499427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein.
    Banks WA; Farr SA; Butt W; Kumar VB; Franko MW; Morley JE
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1113-21. PubMed ID: 11356936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.
    Chernet E; Martin LJ; Li D; Need AB; Barth VN; Rash KS; Phebus LA
    Life Sci; 2005 Dec; 78(4):340-6. PubMed ID: 16139310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dose and input rate on the brain penetration of BMS-204352 following intravenous administration to rats.
    Krishna R; Palme H; Zeng J; Srinivas N
    Biopharm Drug Dispos; 2002 Sep; 23(6):227-31. PubMed ID: 12214322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetration of interleukin-6 across the murine blood-brain barrier.
    Banks WA; Kastin AJ; Gutierrez EG
    Neurosci Lett; 1994 Sep; 179(1-2):53-6. PubMed ID: 7845624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system.
    Banks WA; Niehoff ML; Zalcman SS
    Brain Behav Immun; 2004 Sep; 18(5):434-42. PubMed ID: 15265536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
    Isakovic AJ; Abbott NJ; Redzic ZB
    J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of an influx transporter in the blood-brain barrier transport of naloxone.
    Suzuki T; Ohmuro A; Miyata M; Furuishi T; Hidaka S; Kugawa F; Fukami T; Tomono K
    Biopharm Drug Dispos; 2010 May; 31(4):243-52. PubMed ID: 20437463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-brain barrier transport kinetics of the cyclic depsipeptide mycotoxins beauvericin and enniatins.
    Taevernier L; Bracke N; Veryser L; Wynendaele E; Gevaert B; Peremans K; De Spiegeleer B
    Toxicol Lett; 2016 Sep; 258():175-184. PubMed ID: 27349679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone.
    Martins JM; Kastin AJ; Banks WA
    Neuroendocrinology; 1996 Apr; 63(4):338-48. PubMed ID: 8739889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.
    Kastin AJ; Akerstrom V; Pan W
    J Mol Neurosci; 2002; 18(1-2):7-14. PubMed ID: 11931352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa.
    Banks WA; Jumbe NL; Farrell CL; Niehoff ML; Heatherington AC
    Eur J Pharmacol; 2004 Nov; 505(1-3):93-101. PubMed ID: 15556141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.